Cargando…

Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas

Detalles Bibliográficos
Autores principales:	La Rosa, Alonso, Gutierrez, Alonso N, Odia, Yazmin, McDermott, Michael W, Ahluwalia, Manmeet S, Mehta, Minesh P, Kotecha, Rupesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290511/ https://www.ncbi.nlm.nih.gov/pubmed/37358937 http://dx.doi.org/10.1093/noajnl/vdad074

Ejemplares similares

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
por: Ozair, Ahmad, et al.
Publicado: (2023)

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance
por: Tonse, Raees, et al.
Publicado: (2021)

33. SYSTEMATIC REVIEW AND META-ANALYSIS OF BREAST CANCER BRAIN METASTASIS AND PRIMARY TUMOR RECEPTOR EXPRESSION DISCORDANCE
por: Kotecha, Rupesh, et al.
Publicado: (2020)

Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States
por: Tonse, Raees, et al.
Publicado: (2021)

Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
por: Kutuk, Tugce, et al.
Publicado: (2022)

Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Evaluating the intracranial activity of adagrasib
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Erratum to: Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
por: Odia, Yazmin, et al.
Publicado: (2022)

Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
por: Odia, Yazmin, et al.
Publicado: (2022)

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife(®) Icon™ Stereotactic Radiosurgery for Brain Metastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Update on the Management of Brain Metastasis
por: Singh, Karanvir, et al.
Publicado: (2022)

Re-irradiation alternatives for recurrent high-grade glioma
por: Dong, Yuanli, et al.
Publicado: (2016)

Re-irradiation for high-grade gliomas: Has anything changed?
por: García-Cabezas, Sonia, et al.
Publicado: (2021)

Hospitalization rates for complications due to systemic therapy in the United States
por: Saxena, Anshul, et al.
Publicado: (2021)

OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery
por: Tolakanahalli, Ranjini, et al.
Publicado: (2023)

Relationship between insurance status and interhospital transfers among cancer patients in the United States
por: Rubens, Muni, et al.
Publicado: (2022)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

CLRM-10 METIS (EF-25): A PIVOTAL, RANDOMIZED CONTROLLED STUDY OF TUMOR TREATING FIELDS IN PATIENTS WITH 1–10 BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
por: Mehta, Minesh, et al.
Publicado: (2022)

A study on inter‐planner plan quality variability using a manual planning‐ or Lightning dose optimizer‐approach for single brain lesions treated with the Gamma Knife(®) Icon™
por: Lee, Yongsook C., et al.
Publicado: (2023)

Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases
por: La Rosa, Alonso, et al.
Publicado: (2023)

Hospitalization rates from radiotherapy complications in the United States
por: Tonse, Raees, et al.
Publicado: (2022)

A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG)
por: Amichetti, Maurizio, et al.
Publicado: (2011)

The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma
por: Chan, Joseph, et al.
Publicado: (2020)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Brain metastasis and treatment
por: Ahluwalia, Manmeet S., et al.
Publicado: (2014)

Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges
por: Rahmathulla, Gazanfar, et al.
Publicado: (2013)

Concurrent immunotherapy and re‐irradiation utilizing stereotactic body radiotherapy for recurrent high‐grade gliomas
por: Mahase, Sean S., et al.
Publicado: (2023)

Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma †
por: Datta, Debanjali, et al.
Publicado: (2023)

Expert consensus on re-irradiation for recurrent glioma
por: Krauze, Andra, et al.
Publicado: (2017)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA: AN ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL AND PREDICTORS OF RADIATION NECROSIS
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6hrv5egg2ug81stmsh5mkdm3nk